Alvarado et al. showed that in GBM, cancer stem cells have low TLR4 expression which enables cell survival by avoiding inhibitory innate immune signaling (e.g., clearance by dendritic cells, cytotoxic T cells, and natural killer cells) that aims to suppress self-renewal of the GBM stem cells (140). The gene discussed is TLR4; the disease is glioblastoma.